Brief: Tot Biopharm International Says 9M Revenue RMB305.8 Mln
09/11/2022 10:39
Nov 9 (Reuters) - TOT BIOPHARM International Co Ltd
1875.HK :
* 9M REVENUE RMB305.8 MILLION VERSUS RMB36.2 MILLION
* NINE MONTH LOSS ATTRIBUTABLE RMB40.5 MILLION VERSUS LOSS
RMB177.9 MILLION
Source text for Eikon: ID:nHKS6RGz8Z
Further company coverage: 1875.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioDlink International
See all newsCorrected: China's BioDlink International HY revenue falls (September 29)
Brief: Biodlink International To Deliver Ten Batches Of Monoclonal Antibody Intermediates To Wuxi Biologics
Brief: Biodlink International Says Shan Fu Resigns As Executive Director And Chairperson
Brief: BioDlink International Says WuXi XDC Cayman To Make Conditional Cash Offer For All Co Shares
Brief: HKEX Says Trading In Shares Of Biodlink International Will Be Halted At Dec 29